SCHEMBL3977604

SCHEMBL3977604

N#Cc1c(O)ccc(C(=O)OC(=O)c2occ(-c3ccncc3)c2-c2ccccc2)c1C(=O)NN

nearest known ligand 0.39

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.33
GAA P10253 2/20 0.33
HPGD P15428 1/20 0.33
MAPT P10636 2/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
SQOR Q9Y6N5 1/20 0.32
ADORA1 P30542 2/20 0.32
CDC7 O00311 1/20 0.32
DBF4 Q9UBU7 1/20 0.32
IKBKB O14920 2/20 0.31
CHUK O15111 1/20 0.31
IKBKE Q14164 1/20 0.31
PKMYT1 Q99640 1/20 0.31
ADORA2A P29274 1/20 0.31
ESR1 P03372 1/20 0.31
POLB P06746 1/20 0.31
PKM P14618 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3975937 0.95 ALDH1A1 (0.36) ALDH1A1GAAHPGDMAPTSMN1; SMN2
SCHEMBL3979485 0.88 MAPT (0.41) ALDH1A1GAAHPGDMAPTSMN1; SMN2
SCHEMBL3975288 0.86 KDM4E (0.33) ALDH1A1GAAMAPTTDP1ADORA1
SCHEMBL3976993 0.86 ALDH1A1 (0.35) ALDH1A1GAAHPGDMAPTTDP1
SCHEMBL3978288 0.86 ALDH1A1 (0.34) ALDH1A1GAAHPGDMAPTSMN1; SMN2
SCHEMBL3974992 0.86 CA12 (0.31) MAPT
SCHEMBL3985231 0.85 ALDH1A1 (0.34) ALDH1A1GAAHPGD
SCHEMBL3985003 0.85 NPC1 (0.34) ALDH1A1MAPTSMN1; SMN2TDP1ESR1
SCHEMBL3974971 0.84 ALDH1A1 (0.38) ALDH1A1GAAHPGDMAPTSMN1; SMN2
SCHEMBL3981614 0.84 ALOX15 (0.34) ALDH1A1GAAHPGDMAPTTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7514452-B2 2-furancarboxylic acid hydrazides and pharmaceutical compositions containing the same DAINIPPON PHARMACEUTICAL CO., LTD (JP) 2009-04-07 US disclosed
US-20050171196-A1 2-Furancarboxylic acid hydrazides and pharmaceutical compositions containing the same DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2005-08-04 US disclosed
EP-1489077-A1 2-FURANCARBOXYLIC ACID HYDRAZIDES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME DAINIPPON PHARMACEUTICAL CO., LTD. (JP) 2004-12-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050171196-A1 2-Furancarboxylic acid hydrazides and pharmaceutical compositions containing the same GLP1R, GCGR, GPR119 ALDH1A1 1389/4885GAA 1023/4885HPGD 299/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.